{"id":"W4385514316","doi":"10.3324/haematol.2022.281780","title":"Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"Swedish Orphan Biovitrum; BioCryst; Apellis Pharmaceuticals; Regeneron Pharmaceuticals; UCB Pharma; Alexion Pharmaceuticals; Amgen","keywords":"Paroxysmal nocturnal hemoglobinuria; Hemoglobinuria; Medicine; Internal medicine; Anemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001432735,0.0005348168,0.003018468,0.0005036108,0.000137785,0.00001596681,0.0008248052,0.001524269,0.006676684],"category_scores_gemma":[0.001299939,0.0004111658,0.0006086809,0.0002994387,0.0002894283,0.0000417747,0.0003866287,0.001296916,0.001084556],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006837774,"about_ca_system_score_gemma":0.0001691143,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001380334,"about_ca_topic_score_gemma":0.00003844667,"domain_scores_codex":[0.994087,0.002022313,0.002330663,0.00067247,0.0001247776,0.0007627694],"domain_scores_gemma":[0.9958438,0.001880753,0.001448537,0.0007244922,0.00007684402,0.00002561388],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003684549,0.0004149051,0.0003956984,0.0004449739,0.0003739668,0.001382692,0.0001364232,9.993977e-7,0.003259383,0.0001010725,0.9927001,0.0004213382],"study_design_scores_gemma":[0.00948854,0.001407161,0.0002730401,0.0009597607,0.0003357443,0.0007684588,0.0001407587,0.000001763653,0.007374846,0.00141241,0.9771451,0.000692433],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7366642,0.01227096,0.00003122112,0.2248009,0.01010453,0.004795539,0.007417815,0.0008397771,0.003074995],"genre_scores_gemma":[0.875571,0.0002148639,0.0001535981,0.09349799,0.001528725,0.001004938,0.01317547,0.0002024125,0.01465107],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1389067,"threshold_uncertainty_score":0.999834,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.112899291390924,"score_gpt":0.3572159072057279,"score_spread":0.2443166158148039,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}